NICE recommends weekly insulin jab for type 2 diabetes in final draft guidance

Hundreds of thousands of adults with type 2 diabetes could be offered a once-weekly insulin injection under new draft guidance from the National Institute for Health and Care Excellence (NICE). NICE has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, which could cut the number of injections for people currently...Read moreThe post NICE recommends weekly insulin jab for type 2 diabetes in final draft guidance appeared first on Nursing in Practice.